ALDER BIOPHARMACEUTICALS INC Operating Expenses
ALDER BIOPHARMACEUTICALS INC reported Operating Expenses of $55.76 million for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-08-06
- ALDER BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2019-06-30 was $55.76M, a 13.86% decline year-over-year.
- ALDER BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2019-03-31 was $114.09M, a 33.28% increase year-over-year.
- ALDER BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2018-12-31 was $77.42M, a 38.20% increase year-over-year.
- ALDER BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2018-09-30 was $58.48M, a 3.22% decline year-over-year.
- ALDER BIOPHARMACEUTICALS INC operating expenses for fiscal 2018 was $286.58M, a 2.06% decline from fiscal 2017.
- ALDER BIOPHARMACEUTICALS INC operating expenses for fiscal 2017 was $292.62M, a 84.02% increase from fiscal 2016.
- ALDER BIOPHARMACEUTICALS INC operating expenses for fiscal 2016 was $159.02M, a 84.20% increase from fiscal 2015.
- ALDER BIOPHARMACEUTICALS INC operating expenses for fiscal 2015 was $86.33M, a 88.08% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2019-06-30 | $55.76M 10-Q · filed 2019-08-06 | $169.84M 10-Q · filed 2019-08-06 | $247.27M derived: sum of 3 quarters · filed 2019-08-06 | $305.75M derived: sum of 4 quarters · filed 2019-08-06 | ||
| 2019-03-31 | $114.09M 10-Q · filed 2019-05-02 | $191.51M derived: sum of 2 quarters · filed 2019-05-02 | $249.99M derived: sum of 3 quarters · filed 2019-05-02 | $314.72M derived: sum of 4 quarters · filed 2019-08-06 | ||
| 2018-12-31 | $77.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $135.90M derived: sum of 2 quarters · filed 2019-02-25 | $200.63M derived: sum of 3 quarters · filed 2019-08-06 | $286.58M 10-K · filed 2019-02-25 | ||
| 2018-09-30 | $58.48M 10-Q · filed 2018-11-05 | $123.21M derived: sum of 2 quarters · filed 2019-08-06 | $209.16M 10-Q · filed 2018-11-05 | $264.83M derived: sum of 4 quarters · filed 2019-08-06 | ||
| 2018-06-30 | $64.73M 10-Q · filed 2019-08-06 | $64.97M 10-Q · filed 2018-08-07 | $150.33M 10-Q · filed 2019-08-06 | $150.68M 10-Q · filed 2018-08-07 | $206.35M derived: sum of 3 quarters · filed 2019-08-06 | $266.78M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $85.60M 10-Q · filed 2019-05-02 | $85.71M 10-Q · filed 2018-05-08 | $141.62M derived: sum of 2 quarters · filed 2019-05-02 | $202.05M derived: sum of 3 quarters · filed 2019-05-02 | $277.55M derived: sum of 4 quarters · filed 2019-05-02 | |
| 2017-12-31 | $56.02M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $116.45M derived: sum of 2 quarters · filed 2019-02-25 | $191.95M derived: sum of 3 quarters · filed 2019-02-25 | $292.62M 10-K · filed 2019-02-25 | ||
| 2017-09-30 | $60.42M 10-Q · filed 2018-11-05 | $135.93M derived: sum of 2 quarters · filed 2018-11-05 | $236.60M 10-Q · filed 2018-11-05 | $285.79M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-06-30 | $75.51M 10-Q · filed 2018-08-07 | $176.18M 10-Q · filed 2018-08-07 | $225.36M derived: sum of 3 quarters · filed 2019-02-25 | $261.09M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-03-31 | $100.67M 10-Q · filed 2018-05-08 | $149.86M derived: sum of 2 quarters · filed 2019-02-25 | $185.59M derived: sum of 3 quarters · filed 2019-02-25 | $226.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2016-12-31 | $49.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $84.92M derived: sum of 2 quarters · filed 2019-02-25 | $125.33M derived: sum of 3 quarters · filed 2019-02-25 | $159.02M 10-K · filed 2019-02-25 | ||
| 2016-09-30 | $35.73M 10-Q · filed 2017-11-07 | $76.14M derived: sum of 2 quarters · filed 2017-11-07 | $109.83M 10-Q · filed 2017-11-07 | $136.26M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-06-30 | $40.41M 10-Q · filed 2017-08-08 | $74.10M 10-Q · filed 2017-08-08 | $100.53M derived: sum of 3 quarters · filed 2018-02-26 | $127.70M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-03-31 | $33.69M 10-Q · filed 2017-04-27 | $60.12M derived: sum of 2 quarters · filed 2018-02-26 | $87.29M derived: sum of 3 quarters · filed 2018-02-26 | $105.31M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2015-12-31 | $26.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $53.60M derived: sum of 2 quarters · filed 2018-02-26 | $71.62M derived: sum of 3 quarters · filed 2018-02-26 | $86.33M 10-K · filed 2018-02-26 | ||
| 2015-09-30 | $27.17M 10-Q · filed 2015-11-05 | $45.19M derived: sum of 2 quarters · filed 2015-11-05 | $59.90M 10-Q · filed 2015-11-05 | $73.30M derived: sum of 4 quarters · filed 2016-04-28 | ||
| 2015-06-30 | $18.02M 10-Q · filed 2015-08-05 | $32.73M 10-Q · filed 2015-08-05 | $46.13M derived: sum of 3 quarters · filed 2016-04-28 | $56.34M derived: sum of 4 quarters · filed 2016-04-28 | ||
| 2015-03-31 | $14.71M 10-Q · filed 2016-04-28 | $28.11M derived: sum of 2 quarters · filed 2016-04-28 | $38.32M derived: sum of 3 quarters · filed 2016-04-28 | $50.43M derived: sum of 4 quarters · filed 2016-04-28 | ||
| 2014-12-31 | $13.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $23.61M derived: sum of 2 quarters · filed 2016-02-23 | $35.72M derived: sum of 3 quarters · filed 2016-02-23 | $45.90M 10-K · filed 2016-02-23 | ||
| 2014-09-30 | $10.21M 10-Q · filed 2015-11-05 | $22.32M derived: sum of 2 quarters · filed 2015-11-05 | $32.50M 10-Q · filed 2015-11-05 | $41.19M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $12.11M 10-Q · filed 2015-08-05 | $22.29M 10-Q · filed 2015-08-05 | $30.98M derived: sum of 3 quarters · filed 2016-02-23 | $41.76M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $10.18M 10-Q · filed 2015-05-07 | $18.87M derived: sum of 2 quarters · filed 2016-02-23 | $29.65M derived: sum of 3 quarters · filed 2016-02-23 | $39.43M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2013-12-31 | $8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $19.47M derived: sum of 2 quarters · filed 2016-02-23 | $29.25M derived: sum of 3 quarters · filed 2016-02-23 | $39.56M 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $10.78M 10-Q · filed 2014-11-03 | $20.57M derived: sum of 2 quarters · filed 2014-11-03 | $30.87M 10-Q · filed 2014-11-03 | |||
| 2013-06-30 | $9.79M 10-Q · filed 2014-08-05 | $20.09M 10-Q · filed 2014-08-05 | ||||
| 2013-03-31 | $10.30M 10-Q · filed 2014-06-20 | |||||
| 2012-12-31 | $37.89M 10-K · filed 2015-03-13 |